News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Canada study of Merck's COVID-19 oral treatment is moving more slowly - health minister

01/17/2022 | 02:13pm EDT

OTTAWA, Jan 17 (Reuters) - Canada's study into whether to approve Merck & Co Inc's COVID-19 oral antiviral treatment "is moving more slowly", federal Health Minister Jean-Yves Duclos said on Monday.

"There are some specific issues for this medication," Duclos told reporters after Ottawa approved an oral antiviral treatment by Pfizer Inc, but did not give details. In its pivotal clinical trial, Merck's pill had less impressive results than the one produced by Pfizer. (Reporting by David Ljunggren)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION -1.01% 55.89 Delayed Quote.-16.87%
PFIZER, INC. 0.78% 52.88 Delayed Quote.-11.14%
Latest news "Economy & Forex"
05:34pBrazil set to make another 10% cut in import tax rates
RE
05:34pHealth Care Up on Cyclical Bias -- Health Care Roundup
DJ
05:32pBrazil's Cosan subsidiary Moove acquires U.S. PetroChoice Lubrication
RE
05:32pIndustrials Up as Recession Fears Ease -- Industrials Roundup
DJ
05:30pDogecoin Lost 0.78% to $0.084 at 5 p.m. ET -- Data Talk
DJ
05:30pEthereum Lost 0.42% to $1996.35 at 5 p.m. ET -- Data Talk
DJ
05:30pBitcoin Lost 2.08% to $29288.98 at 5 p.m. ET -- Data Talk
DJ
05:29pMaterials Up as Global Recession Fears Ease -- Materials Roundup
DJ
05:25pEnergy Up as Gasoline, Natural Gas Near Record Highs -- Energy Roundup
DJ
05:24pNo immediate need for mass monkeypox vaccinations - WHO official
RE
Latest news "Economy & Forex"